中藥制造行業知名品牌,隸屬于中恒集團,集種植、生產、銷售、研發于一體的現代化綜合型制藥企業,涵蓋中華/晨鐘/中恒等品牌
廣西梧(wu)州制(zhi)(zhi)藥(yao)(yao)(集團)股(gu)份(fen)有(you)限公司(si)(si)(簡稱梧(wu)州制(zhi)(zhi)藥(yao)(yao)),是(shi)上(shang)市(shi)公司(si)(si)中(zhong)(zhong)恒集團(股(gu)票代碼:600252)的下(xia)屬(shu)企(qi)業(ye),系出嶺(ling)南(nan)中(zhong)(zhong)藥(yao)(yao)之鄉(xiang)。嶺(ling)南(nan)中(zhong)(zhong)藥(yao)(yao),歷(li)史悠久(jiu),名揚中(zhong)(zhong)華,民族(zu)瑰寶。梧(wu)州制(zhi)(zhi)藥(yao)(yao)在近(jin)90年的發展歷(li)史中(zhong)(zhong),已成(cheng)為集種(zhong)植(zhi)、生產、銷售、研發于一體的現代化綜(zong)合(he)型制(zhi)(zhi)藥(yao)(yao)企(qi)業(ye),是(shi)國(guo)家(jia)高新技術(shu)企(qi)業(ye)。
梧州制(zhi)藥(yao)(yao)(yao)(yao)(yao)資源豐富,擁有(you)化學(xue)(xue)原料(liao)藥(yao)(yao)(yao)(yao)(yao)、中(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)注射劑等14個(ge)(ge)(ge)(ge)(ge)大類劑型217個(ge)(ge)(ge)(ge)(ge)品(pin)(pin)(pin)(pin)(pin)種(zhong)(zhong)(zhong)(其中(zhong)(zhong)中(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)制(zhi)劑135個(ge)(ge)(ge)(ge)(ge),化學(xue)(xue)藥(yao)(yao)(yao)(yao)(yao)82個(ge)(ge)(ge)(ge)(ge)),擁有(you)藥(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)(pin)(pin)注冊證309個(ge)(ge)(ge)(ge)(ge),獲國家專利(li)55個(ge)(ge)(ge)(ge)(ge),全(quan)(quan)國獨有(you)生產(chan)品(pin)(pin)(pin)(pin)(pin)種(zhong)(zhong)(zhong)24個(ge)(ge)(ge)(ge)(ge),《中(zhong)(zhong)國藥(yao)(yao)(yao)(yao)(yao)典》收(shou)載品(pin)(pin)(pin)(pin)(pin)種(zhong)(zhong)(zhong)105個(ge)(ge)(ge)(ge)(ge),國家中(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)保(bao)(bao)護品(pin)(pin)(pin)(pin)(pin)種(zhong)(zhong)(zhong)5個(ge)(ge)(ge)(ge)(ge),國家醫(yi)保(bao)(bao)目錄品(pin)(pin)(pin)(pin)(pin)種(zhong)(zhong)(zhong)86個(ge)(ge)(ge)(ge)(ge)(其中(zhong)(zhong)中(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)(pin)(pin)種(zhong)(zhong)(zhong)54個(ge)(ge)(ge)(ge)(ge),西藥(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)(pin)(pin)種(zhong)(zhong)(zhong)32個(ge)(ge)(ge)(ge)(ge))國家基本藥(yao)(yao)(yao)(yao)(yao)物目錄品(pin)(pin)(pin)(pin)(pin)種(zhong)(zhong)(zhong)45個(ge)(ge)(ge)(ge)(ge)(其中(zhong)(zhong)中(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)(pin)(pin)種(zhong)(zhong)(zhong)31個(ge)(ge)(ge)(ge)(ge),化學(xue)(xue)藥(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)(pin)(pin)及生物制(zhi)品(pin)(pin)(pin)(pin)(pin)14個(ge)(ge)(ge)(ge)(ge)),以(yi)及“中(zhong)(zhong)華”、“晨鐘(zhong)”和“中(zhong)(zhong)恒”等品(pin)(pin)(pin)(pin)(pin)牌,擁有(you)注射用(yong)血(xue)栓通(tong)、婦炎(yan)凈膠(jiao)囊、中(zhong)(zhong)華跌打丸、結石通(tong)片等主導產(chan)品(pin)(pin)(pin)(pin)(pin)。在發展過程中(zhong)(zhong),梧州制(zhi)藥(yao)(yao)(yao)(yao)(yao)視產(chan)品(pin)(pin)(pin)(pin)(pin)質(zhi)量為企(qi)業的(de)生命(ming)和患者的(de)生命(ming),嚴格按照GMP要(yao)求,不(bu)斷完善質(zhi)量管(guan)理體系(xi)和檢測手段,加強質(zhi)量全(quan)(quan)程監管(guan),保(bao)(bao)障藥(yao)(yao)(yao)(yao)(yao)品(pin)(pin)(pin)(pin)(pin)質(zhi)量安全(quan)(quan)。
梧州制藥大力實施“產(chan)(chan)業興(xing)國,科技(ji)強(qiang)企(qi)”的(de)(de)創(chuang)新(xin)戰略,以(yi)(yi)(yi)資(zi)金(jin)為(wei)保障,以(yi)(yi)(yi)人才(cai)為(wei)依(yi)托,以(yi)(yi)(yi)科技(ji)為(wei)動力,以(yi)(yi)(yi)市場(chang)為(wei)導向(xiang),以(yi)(yi)(yi)效益為(wei)中心,以(yi)(yi)(yi)發(fa)展為(wei)目標,充分發(fa)揮自身技(ji)術(shu)人才(cai)和(he)技(ji)術(shu)平臺優(you)勢(shi),推動自主創(chuang)新(xin)驅動,加(jia)強(qiang)對(dui)中藥前沿技(ji)術(shu)、新(xin)工藝、新(xin)產(chan)(chan)品(pin)的(de)(de)研發(fa),以(yi)(yi)(yi)及老產(chan)(chan)品(pin)的(de)(de)二次開發(fa),促(cu)進(jin)產(chan)(chan)品(pin)結構(gou)和(he)產(chan)(chan)業升級,增強(qiang)產(chan)(chan)品(pin)的(de)(de)市場(chang)競爭(zheng)力、產(chan)(chan)業的(de)(de)發(fa)展競爭(zheng)力和(he)企(qi)業的(de)(de)核心競爭(zheng)力。
梧州制(zhi)藥(yao)(yao)是我國(guo)中(zhong)(zhong)藥(yao)(yao)制(zhi)造(zao)前端(duan)的(de)一顆璀璨明珠,專注于研制(zhi)造(zao)福眾生的(de)純正好(hao)藥(yao)(yao)。“十三(san)五”期間,將圍繞醫藥(yao)(yao)健(jian)(jian)康(kang)領(ling)域的(de)傳承(cheng)與(yu)創(chuang)新(xin),以(yi)中(zhong)(zhong)藥(yao)(yao)產(chan)業(ye)(ye)(ye)(ye)鏈為(wei)主(zhu)體,以(yi)消(xiao)費(fei)者健(jian)(jian)康(kang)為(wei)延(yan)伸(shen),以(yi)特色(se)化(hua)學藥(yao)(yao)為(wei)補(bu)充,抓住國(guo)家(jia)“十三(san)五”建成小康(kang)社會和(he)落(luo)實(shi)“健(jian)(jian)康(kang)中(zhong)(zhong)國(guo)”的(de)戰略規劃的(de)時(shi)機,以(yi)國(guo)家(jia)大(da)力(li)促進中(zhong)(zhong)醫藥(yao)(yao)事(shi)業(ye)(ye)(ye)(ye)發(fa)展、大(da)力(li)推動醫藥(yao)(yao)科(ke)技(ji)創(chuang)新(xin)、大(da)力(li)發(fa)展健(jian)(jian)康(kang)服(fu)務業(ye)(ye)(ye)(ye)為(wei)契機,利用廣西地方政府(fu)大(da)力(li)推進中(zhong)(zhong)醫藥(yao)(yao)壯瑤(yao)醫藥(yao)(yao)現代化(hua)的(de)機遇,結合(he)(he)公司(si)的(de)市場與(yu)資(zi)源優勢,努力(li)成為(wei)廣西醫藥(yao)(yao)健(jian)(jian)康(kang)資(zi)源的(de)整合(he)(he)者,定位于打造(zao)兩廣區域、國(guo)內有影響力(li)的(de)醫藥(yao)(yao)產(chan)業(ye)(ye)(ye)(ye)綜合(he)(he)企業(ye)(ye)(ye)(ye)。